epirubicin has been researched along with Nail Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Helmer, H; Kurz, C; Obermair, A; Pehamberger, K; Sevelda, P; Vavra, N | 1 |
1 other study(ies) available for epirubicin and Nail Diseases
Article | Year |
---|---|
Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fingers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Nail Diseases; Ovarian Neoplasms; Toes | 1995 |